Lem Holding SA
SIX:LEHN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lem Holding SA
SIX:LEHN
|
CH |
|
Ultralife Corp
NASDAQ:ULBI
|
US |
|
RTL Group SA
OTC:RGLXF
|
LU |
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
C
|
Cowealth Medical China Co Ltd
SSE:603122
|
CN |
|
Z
|
Zhuhai Kles Technology Co Ltd
SZSE:301314
|
CN |
|
Piccadily Agro Industries Ltd
NSE:PICCADIL
|
IN |
|
Western Gold Exploration Ltd
XTSX:WGLD
|
CA |
|
Big Lots Inc
OTC:BIGGQ
|
US |
|
M
|
Mynaric AG
XBER:M0YN
|
DE |
Wall Street
Price Targets
LEHN Price Targets Summary
Lem Holding SA
According to Wall Street analysts, the average 1-year price target for
LEHN
is 389.3 CHF
with a low forecast of 363.6 CHF and a high forecast of 430.5 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LEHN's stock price target?
Price Target
389.3
CHF
According to Wall Street analysts, the average 1-year price target for
LEHN
is 389.3 CHF
with a low forecast of 363.6 CHF and a high forecast of 430.5 CHF.
What is Lem Holding SA's Revenue forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
Lem Holding SA's revenue is
2%.
The projected
CAGR
for the next 4 years is
3%.
What is Lem Holding SA's Operating Income forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Lem Holding SA's operating income is
-2%.
The projected
CAGR
for the next 4 years is
14%.
What is Lem Holding SA's Net Income forecast?
Projected CAGR
24%
For the last 13 years the
compound annual growth rate for
Lem Holding SA's net income is
-9%.
The projected
CAGR
for the next 4 years is
24%.
